|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 68.8 TWD | -0.58% |
|
-0.15% | -8.02% |
| Mar. 15 | Bionime Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 14 | Bionime Corporation Announces Dividend for the Year Ended December 31, 2023 | CI |
Bionime Corporation reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was TWD 1,755.57 million compared to TWD 2,210.59 million a year ago. Net income was TWD 6.21 million compared to TWD 91.03 million a year ago.
Basic earnings per share from continuing operations was TWD 0.1 compared to TWD 1.5 a year ago. Diluted earnings per share from continuing operations was TWD 0.1 compared to TWD 1.48 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -8.02% | 129M | |
| +0.89% | 12.8B | |
| -10.29% | 7.61B | |
| +1.78% | 5.41B | |
| -1.16% | 4.51B | |
| +5.74% | 4.49B | |
| -50.70% | 3.3B | |
| +12.21% | 2.73B | |
| -16.13% | 2.02B | |
| -11.50% | 1.73B |
BIONIME CORPORATION 
